Application of tetrahydropalmatine in preparation of medicine for treating atopic dermatitis

The invention provides an application of tetrahydropalmatine in preparation of a medicine for treating atopic dermatitis. According to the application disclosed by the invention, the treatment of the atopic dermatitis by the tetrahydropalmatine is researched, and the research shows that the tetrahydropalmatine can be used for obviously improving the atopic dermatitis caused by calcipotriol and inhibiting skin epidermal barrier damage, pruritus factor release and inflammatory factor release caused by the tetrahydropalmatine, so that the tetrahydropalmatine can be used for treating the atopic dermatitis..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 24. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

WANG NAN [VerfasserIn]
ZHANG YONGJING [VerfasserIn]
HU SHILING [VerfasserIn]
ZHANG XINPING [VerfasserIn]
HE LANGCHONG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-24, Last update posted on www.tib.eu: 2024-02-05, Last updated: 2024-02-09

Patentnummer:

CN117100746

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA019154879